• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Amryt Pharma plc

    Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    High Court of Justice of England and Wales Sanctions Scheme of Arrangement
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    European Commission approves Mycapssa® for the treatment of Acromegaly
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Amryt Announces New Patent for Mycapssa®
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Amryt Reports Q3 2022 Financial and Operational Results
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Amryt Supports Acromegaly Awareness Day 2022
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    The British Journal of Dermatology Publishes Results from Amryt’s EASE Phase 3 Trial in Epidermolysis Bullosa
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Amryt Supports Global EB Awareness Week 2022
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Amryt to Report Q3 2022 Results on November 3, 2022
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    COMP adopts positive opinion on Orphan Disease Designation for Mycapssa® for the treatment of Acromegaly
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin)
    From Amryt Pharma plc
    Via GlobeNewswire
    Tickers AMYT
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.